Table 1

Lung function test results

GenderMaleAge, years69.8RaceOther/mixed
Height, cm171.8Weight, kg96BMI, kg·m−233
Clinical notesIdiopathic pulmonary fibrosis
ActualLLNULNZ-score% pred
Pre-bronchodilator spirometry
 FVC, L1.892.90−3.3148
 FEV1, L1.532.15−2.7752
 FEV1/FVC0.810.630.62
SLVs
 TLC, L2.485.227.99−5.0637
 VC, L1.873.38−4.6944
 FRC, L1.392.434.83−3.809
 RV, L0.613.46−3.44
 RV/TLC, %2547−1.59
CO gas transfer
 IVC, L1.77
VA, L2.504.76−5.41
TLCO, mmol·min−1·kPa−12.315.9510.6−5.6329
TLCOHbcorr, mmol·min−1·kPa−12.45−5.4230
KCO, mmol·min−1·kPa−1·L−10.921.021.76−2.13
KCOHbcorr, mmol·min−1·kPa−1·L−10.98−1.86
 Hb, g·dL−112.612.217.0
Technical commentGrade: spirometry: FEV1 – A, FVC – A; SLV: good; TLCO: AA
Ref: GLI spirometry Caucasian, GLI TLCO, GLI SLV

Results show a restrictive ventilatory defect with gas exchange impairment suggestive of lung parenchymal or pulmonary vascular disease. Reference sets used (Ref) may not be representative of the patient's ethnicity and should be used with caution. BMI: body mass index; LLN: lower limit of normal; ULN: upper limit of normal; FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s; SLV: static lung volume; TLC: total lung capacity; VC: vital capacity; FRC: functional residual capacity; RV: residual volume; IVC: inspiratory vital capacity; VA: alveolar volume; TLCO: transfer across the lung for carbon monoxide; Hbcorr: corrected for haemoglobin; KCO: transfer coefficient of the lung for carbon monoxide; Hb: Haemoglobin; GLI: Global Lung Function Initiative [2–4].